ライフサイエンスコーパス: hilar cholangiocarcinoma

1 ve and only potentially curative therapy for hilar cholangiocarcinoma.

2 section remains the mainstay of treatment of hilar cholangiocarcinoma.

3 herapy followed by liver transplantation for hilar cholangiocarcinoma.

4 ates after aggressive surgical resections of hilar cholangiocarcinoma.

5 t determinant of survival after resection of hilar cholangiocarcinoma.

6 between patients with gallbladder cancer and hilar cholangiocarcinoma.

7 lecystectomy), but only 25% in patients with hilar cholangiocarcinoma.

8 umor extent, the proposed staging system for hilar cholangiocarcinoma accurately predicts resectabili

9 rround the issues of extent of resection for hilar cholangiocarcinoma and whether the histopathology

10 ts receiving endoscopic biliary drainage for hilar cholangiocarcinoma between September 1995 and Dece

11 The yield of laparoscopy is lower for hilar cholangiocarcinoma but can be improved by targetin

12 Sixty-five patients with unresectable hilar cholangiocarcinoma (CCA) have undergone orthotopic

13 In patients with hilar cholangiocarcinoma, concomitant hepatic resection

14 formed a review of the English literature on hilar cholangiocarcinoma from 1990 to 2007.

15 Between 1997 and 2004, 80 patients with hilar cholangiocarcinoma having surgery were reviewed.

16 de (LN) assessment after liver resection for hilar cholangiocarcinoma (HC) is still controversial, an

17 erged as a promising option for unresectable hilar cholangiocarcinoma (hCCA).

18 A total of 257 patients (144 hilar cholangiocarcinoma [HCCA] and 113 distal bile duct

19 ntrahepatic cholangiocarcinoma (IH; n = 23), hilar cholangiocarcinoma (Hilar; n = 54), gallbladder (G

20 ic resection in hepatocellular carcinoma and hilar cholangiocarcinoma improves survival.

21 urvival in patients with surgically resected hilar cholangiocarcinoma in a single institution over th

22 Hilar cholangiocarcinoma is a rare tumor with a poor pro

23 Hilar cholangiocarcinoma is an uncommon tumor with a poo

24 Relief of cholestasis in hilar cholangiocarcinoma is commonly undertaken in both

25 Endoscopic biliary drainage of hilar cholangiocarcinoma is controversial with respect t

26 of intrahepatic cholangiocarcinoma (ICC) and hilar cholangiocarcinoma (Klatskin tumors) is limited to

27 In patients with hilar cholangiocarcinoma, long-term survival depends cri

28 y resectable gallbladder cancer (n = 44) and hilar cholangiocarcinoma (n = 56) were prospectively eva

29 SEMS insertion for the palliation of hilar cholangiocarcinoma offers higher technical and cli

30 s the majority of patients with unresectable hilar cholangiocarcinoma or gallbladder carcinoma, there

31 r the study period was compared with that of hilar cholangiocarcinoma patients (HCCA) seen during the

32 Peri-hilar cholangiocarcinoma (pCCA) is chemorefractory and l

33 ant therapy followed by liver transplant for hilar cholangiocarcinoma, placed in context with the mos

34 From 1985 to 2006, all patients with hilar cholangiocarcinoma referred to a tertiary surgical

35 Hilar cholangiocarcinoma remains a difficult challenge f

36 Ninety patients with hilar cholangiocarcinomas seen between March 1, 1991, an

37 y gallbladder cancer and patients with T2/T3 hilar cholangiocarcinoma should undergo staging laparosc

38 locally advanced but potentially resectable hilar cholangiocarcinoma, the yield of laparoscopy was g

39 ompares outcome after resection of papillary hilar cholangiocarcinoma to that of the more common nodu

40 uated endoscopic palliation in patients with hilar cholangiocarcinoma using self-expandable metallic

41 urvival was most favorable when resection of hilar cholangiocarcinoma was accomplished with margin-ne

42 ogic, and survival data on all patients with hilar cholangiocarcinoma were analyzed.

43 For patients with early stage hilar cholangiocarcinoma which is unresectable or arisin

44 and bile-duct resection can be performed for hilar cholangiocarcinoma with acceptable mortality, thou